Egzostozin-1 je protein koji je kod ljudi kodiran genom EXT1 .[ 5]
Dužina polipeptidnog lanca je 746 aminokiselina , а molekulska težina 86.255 Da .[ 6]
10 20 30 40 50
MQAKKRYFIL LSAGSCLALL FYFGGLQFRA SRSHSRREEH SGRNGLHHPS
PDHFWPRFPD ALRPFVPWDQ LENEDSSVHI SPRQKRDANS SIYKGKKCRM
ESCFDFTLCK KNGFKVYVYP QQKGEKIAES YQNILAAIEG SRFYTSDPSQ
ACLFVLSLDT LDRDQLSPQY VHNLRSKVQS LHLWNNGRNH LIFNLYSGTW
PDYTEDVGFD IGQAMLAKAS ISTENFRPNF DVSIPLFSKD HPRTGGERGF
LKFNTIPPLR KYMLVFKGKR YLTGIGSDTR NALYHVHNGE DVVLLTTCKH
GKDWQKHKDS RCDRDNTEYE KYDYREMLHN ATFCLVPRGR RLGSFRFLEA
LQAACVPVML SNGWELPFSE VINWNQAAVI GDERLLLQIP STIRSIHQDK
ILALRQQTQF LWEAYFSSVE KIVLTTLEII QDRIFKHISR NSLIWNKHPG
GLFVLPQYSS YLGDFPYYYA NLGLKPPSKF TAVIHAVTPL VSQSQPVLKL
LVAAAKSQYC AQIIVLWNCD KPLPAKHRWP ATAVPVVVIE GESKVMSSRF
LPYDNIITDA VLSLDEDTVL STTEVDFAFT VWQSFPERIV GYPARSHFWD
NSKERWGYTS KWTNDYSMVL TGAAIYHKYY HYLYSHYLPA SLKNMVDQLA
NCEDILMNFL VSAVTKLPPI KVTQKKQYKE TMMGQTSRAS RWADPDHFAQ
RQSCMNTFAS WFGYMPLIHS QMRLDPVLFK DQVSILRKKY RDIERL
Ovaj gen kodira jedan od dva endoplazmatskoretikulimska rezidentna transmembranska tipa II glikoziltransferaza – drugi je EXT2 – koji su uključeni u korak biosinteze elongacije lanca heparan-sulfata . Mutacije u ovom genu uzrokuju oblik I tipa višestruke egzostoze .[ 5]
Pokazano je da EXT1 stupa u interakciju sa TRAP1 .[ 7]
Wuyts W, Van Hul W (2000). "Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes". Hum. Mutat . 15 (3): 220–7. doi :10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K . PMID 10679937 .
Duncan G, McCormick C, Tufaro F (2001). "The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins" . J. Clin. Invest . 108 (4): 511–6. doi :10.1172/JCI13737 . PMC 209410 . PMID 11518722 .
Ogle RF, Dalzell P, Turner G, et al. (1992). "Multiple exostoses in a patient with t(8;11)(q24.11;p15.5)" . J. Med. Genet . 28 (12): 881–3. doi :10.1136/jmg.28.12.881 . PMC 1017169 . PMID 1757967 .
Ahn J, Lüdecke HJ, Lindow S, et al. (1995). "Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1)". Nat. Genet . 11 (2): 137–43. doi :10.1038/ng1095-137 . PMID 7550340 . S2CID 39272385 .
Cook A, Raskind W, Blanton SH, et al. (1993). "Genetic heterogeneity in families with hereditary multiple exostoses" . Am. J. Hum. Genet . 53 (1): 71–9. PMC 1682231 . PMID 8317501 .
Hou J, Parrish J, Lüdecke HJ, et al. (1996). "A 4-megabase YAC contig that spans the Langer-Giedion syndrome region on human chromosome 8q24.1: use in refining the location of the trichorhinophalangeal syndrome and multiple exostoses genes (TRPS1 and EXT1)". Genomics . 29 (1): 87–97. doi :10.1006/geno.1995.1218 . PMID 8530105 .
Hecht JT, Hogue D, Wang Y, et al. (1997). "Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies" . Am. J. Hum. Genet . 60 (1): 80–6. PMC 1712567 . PMID 8981950 .
Lüdecke HJ, Ahn J, Lin X, et al. (1997). "Genomic organization and promoter structure of the human EXT1 gene". Genomics . 40 (2): 351–4. doi :10.1006/geno.1996.4577 . PMID 9119404 .
Philippe C, Porter DE, Emerton ME, et al. (1997). "Mutation screening of the EXT1 and EXT2 genes in patients with hereditary multiple exostoses" . Am. J. Hum. Genet . 61 (3): 520–8. doi :10.1086/515505 . PMC 1715939 . PMID 9326317 .
Wuyts W, Van Hul W, De Boulle K, et al. (1998). "Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses" . Am. J. Hum. Genet . 62 (2): 346–54. doi :10.1086/301726 . PMC 1376901 . PMID 9463333 .
Raskind WH, Conrad EU, Matsushita M, et al. (1998). "Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses". Hum. Mutat . 11 (3): 231–9. doi :10.1002/(SICI)1098-1004(1998)11:3<231::AID-HUMU8>3.0.CO;2-K . PMID 9521425 .
McCormick C, Leduc Y, Martindale D, et al. (1998). "The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate". Nat. Genet . 19 (2): 158–61. doi :10.1038/514 . PMID 9620772 . S2CID 25832441 .
Lin X, Gan L, Klein WH, Wells D (1998). "Expression and functional analysis of mouse EXT1, a homolog of the human multiple exostoses type 1 gene". Biochem. Biophys. Res. Commun . 248 (3): 738–43. doi :10.1006/bbrc.1998.9050 . PMID 9703997 .
Lind T, Tufaro F, McCormick C, et al. (1998). "The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate" . J. Biol. Chem . 273 (41): 26265–8. doi :10.1074/jbc.273.41.26265 . PMID 9756849 .
Bovée JV, Cleton-Jansen AM, Wuyts W, et al. (1999). "EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas" . Am. J. Hum. Genet . 65 (3): 689–98. doi :10.1086/302532 . PMC 1377975 . PMID 10441575 .
Xu L, Xia J, Jiang H, et al. (1999). "Mutation analysis of hereditary multiple exostoses in the Chinese". Hum. Genet . 105 (1–2): 45–50. doi :10.1007/s004390051062 . PMID 10480354 .
Simmons AD, Musy MM, Lopes CS, et al. (1999). "A direct interaction between EXT proteins and glycosyltransferases is defective in hereditary multiple exostoses" . Hum. Mol. Genet . 8 (12): 2155–64. doi :10.1093/hmg/8.12.2155 . PMID 10545594 .
McCormick C, Duncan G, Goutsos KT, Tufaro F (2000). "The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate" . Proc. Natl. Acad. Sci. U.S.A . 97 (2): 668–73. Bibcode :2000PNAS...97..668M . doi :10.1073/pnas.97.2.668 . PMC 15388 . PMID 10639137 .
Kobayashi S, Morimoto K, Shimizu T, et al. (2000). "Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus". Biochem. Biophys. Res. Commun . 268 (3): 860–7. doi :10.1006/bbrc.2000.2219 . PMID 10679296 .
Šablon:Enzimi metabolizma glikozaminoglikana